Hoste, Eric
Ghent University Hospital · Jessa Hospital · KU Leuven
10 papers on CoChatORCID 0000-0001-9301-8055
Most cited papers
- Verified
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Zhang, Q., Bastard, P., Liu, Z., Le Pen, J., Moncada-Velez, M., Chen, J., Ogishi, M., Sabli, I. K. D., Hodeib, S., Korol, C., et al. (2020) · Science
interferon and immune responsesSARS-CoV-2 and COVID-19 Research
Cited by 2,229
- Verified
Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
16., O. B. O. T. A. D. Q. I. W., Chawla, L. S., Bellomo, R., Bihorac, A., Goldstein, S. L., Siew, E. D., Bagshaw, S. M., Bittleman, D., Cruz, D., Endre, Z., et al. (2017) · Nature Reviews Nephrology
Acute Kidney Injury ResearchChronic Kidney Disease and Diabetes
Cited by 1,537
- Verified
Global epidemiology and outcomes of acute kidney injury
Hoste, E. A. J., Kellum, J. A., Selby, N. M., Zarbock, A., Palevsky, P. M., Bagshaw, S. M., Goldstein, S. L., Cerdá, J., & Chawla, L. S. (2018) · Nature Reviews Nephrology
Acute Kidney Injury ResearchChronic Kidney Disease and Diabetes
Cited by 1,486
- Verified
Recovery after Acute Kidney Injury
Kellum, J. A., Sileanu, F. E., Bihorac, A., Hoste, E. A. J., & Chawla, L. S. (2017) · American Journal of Respiratory and Critical Care Medicine
Acute Kidney Injury ResearchChronic Kidney Disease and Diabetes
Cited by 520
- Verified
Effects of nosocomial candidemia on outcomes of critically ill patients
Blot, S. I., Vandewoude, K. H., Hoste, E. A., & Colardyn, F. A. (2002) · The American Journal of Medicine
Antifungal resistance and susceptibilityNosocomial Infections in ICU
Cited by 235
- Verified
Cytokine removal in human septic shock: Where are we and where are we going?
Honore, P. M., Hoste, E., Molnár, Z., Jacobs, R., Joannes-Boyau, O., Malbrain, M. L. N. G., & Forni, L. G. (2019) · Annals of Intensive Care
Sepsis Diagnosis and TreatmentAcute Kidney Injury Research
Cited by 192
- Verified
Targeting ferroptosis protects against experimental (multi)organ dysfunction and death
Van Coillie, S., Van San, E., Goetschalckx, I., Wiernicki, B., Mukhopadhyay, B., Tonnus, W., Choi, S. M., Roelandt, R., Dumitrascu, C., Lamberts, L., et al. (2022) · Nature Communications
Ferroptosis and cancer prognosisIron Metabolism and Disorders
Cited by 186
- Verified
Targeting ferroptosis protects against multiorgan dysfunction and death.
VandenBerghe, T., Coillie, S. V., Goetschalckx, I., Wiernicki, B., Mukhopadhyay, B., Tonnus, W., San, E. V., Choi, S. M., Roelandt, R., Dumitrascu, C., et al. (2021) · Nature Communications
Ferroptosis and cancer prognosisIron Metabolism and Disorders
Cited by 186
- Verified
Tight blood-glucose control without early parenteral nutrition in the ICU
Gunst, J., Debaveye, Y., Güiza, F., Dubois, J., De Bruyn, A., Dauwe, D., De Troy, E., Casaer, M. P., De Vlieger, G., Haghedooren, R., et al. (2023) · New England Journal of Medicine
Hyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Management and Research
Cited by 163
- Verified
Outcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata
Blot, S., Vandewoude, K., Hoste, E., Poelaert, J., & Colardyn, F. (2001) · Journal of Hospital Infection
Antifungal resistance and susceptibilityFungal Infections and Studies
Cited by 73
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free